EMG
ATOS icon

ETF Managers Group’s Atossa Therapeutics ATOS Stock Holding History

ETF Managers Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$30.8K Buy
2,829
+724
+34% +$8.07K ﹤0.01% 668
2022
Q4 		$16.7K Sell
2,105
-386
-15% -$4.43K ﹤0.01% 510
2022
Q3 		$31K Sell
2,491
-176
-7% -$2.56K ﹤0.01% 682
2022
Q2 		$46K Buy
2,667
+106
+4% +$1.67K ﹤0.01% 714
2022
Q1 		$51K Sell
2,561
-2
-0.1% -$41 ﹤0.01% 657
2021
Q4 		$64K Buy
+2,563
New +$93.8K ﹤0.01% 657

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ETF Managers Group's ATOS Position: Q1 2023 in Review

ETF Managers Group increased its Atossa Therapeutics (ATOS) stake by 34% in Q1 2023, buying an estimated $8.07K and bringing the position to 2,829 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

ETF Managers Group first reported a position in ATOS in Q4 2021 and has held it in 6 quarters since. The position peaked at $64K in Q4 2021. 45 funds tracked by Wall St. Rank hold ATOS as of Q1 2023.

  • ETF Managers Group held 2,829 shares of Atossa Therapeutics worth $30.8K as of Q1 2023.
  • ETF Managers Group bought 724 Atossa Therapeutics shares in Q1 2023, an estimated $8.07K.
  • Atossa Therapeutics made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #668 holding.
  • ETF Managers Group first reported a position in Atossa Therapeutics in Q4 2021 and has held it in 6 quarters since.
  • ETF Managers Group's Atossa Therapeutics position peaked at $64K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.